RBC-Factory Industry Day
ID: DARPA-SN-25-16Type: Special Notice
Overview

Buyer

DEPT OF DEFENSEDEFENSE ADVANCED RESEARCH PROJECTS AGENCY (DARPA)DEF ADVANCED RESEARCH PROJECTS AGCYARLINGTON, VA, 222032114, USA

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

NATIONAL DEFENSE R&D SERVICES; DEPARTMENT OF DEFENSE - MILITARY; APPLIED RESEARCH (AC12)
Timeline
    Description

    The Defense Advanced Research Projects Agency (DARPA) is hosting a virtual Industry Day for the Red Blood Cell Factory (RBC-Factory) program, aimed at enhancing human red blood cells with biologically active components to improve warfighter performance in extreme environments. This event will provide potential proposers with insights into the program's vision, operational mechanics, and opportunities for collaboration, with a focus on innovative proposals that modify red blood cells at scale, explicitly excluding genetic modifications. The Industry Day is scheduled for January 7, 2025, with registration required by January 2, 2025, and is limited to 350 participants on a first-come, first-served basis. Interested parties can direct inquiries to Dr. Christopher Bettinger at RBC-Factory@darpa.mil, and are encouraged to submit a one-page teaming profile detailing their competencies and desired collaborations.

    Point(s) of Contact
    Dr. Christopher Bettinger
    RBC-Factory@darpa.mil
    Files
    Title
    Posted
    The document outlines guidance for proposers participating in a DARPA initiative focused on the RBC-Factory program. It emphasizes the importance of collaborative teams to cover all necessary technical areas and encourages proposers to present a comprehensive yet concise overview on a single PDF slide in landscape orientation. Key elements to include are the primary investigator’s details, an overview of existing team members, their relevant expertise, institutional assets, and core facilities. Proposers must outline their project aims, approaches to technical challenges, program phase structures, and unique metrics for success. There is also a call for identifying specific technical challenges where additional collaboration is needed. Overall, the emphasis is on clear communication and demonstrating how teams can contribute to the program's objectives while adhering to unclassified and non-proprietary guidelines. This document serves to assist potential applicants in developing competitive proposals for federal grants and RFPs.
    The document outlines a proposal process for teams seeking to address candidate discovery and testbed development, aiming to establish collaborative efforts to tackle technical challenges. It emphasizes the necessity of a clear project overview detailing objectives, proposed methodologies, and expected hurdles. The teaming section highlights existing personnel, their expertise, institutional assets, and desired collaborations to overcome specific technical difficulties. Additionally, the anticipated impact of the team's success is addressed, including potential applications, unique metrics for progress, and strategies for transitioning the technology. The proposal encourages unclassified submissions using clear language, avoiding jargon, with a strong recommendation for forming multidisciplinary teams to meet program goals effectively. It sets the framework for stakeholders to submit their proposals, ensuring each section is well-defined and succinct to facilitate understanding and evaluation. This aligns with the objectives common in government RFPs, promoting innovation, collaboration, and the practical application of research in addressing national challenges.
    The Defense Advanced Research Projects Agency (DARPA) is hosting a virtual Proposers Day on January 7, 2025, for the Red Blood Cell Factory (RBC-Factory) program, which aims to develop a medical platform to enhance human red blood cells with biologically active components to improve warfighter performance in extreme environments. The event will provide potential proposers with insights into the program's vision, operational mechanics, and team collaboration opportunities. Participants can engage in "lightning talks" to showcase their capabilities and request virtual meetings with the program manager for further discussions. Registration is required by January 2, 2025, limited to 350 participants on a first-come, first-served basis. The RBC-Factory program seeks innovative proposals focused on modifying red blood cells at scale, explicitly excluding approaches that involve genetic modifications. Attendees are encouraged to submit a one-page teaming profile detailing their competencies and desired collaboration. This Proposers Day serves as an information-gathering and networking opportunity to foster partnerships, facilitate proposal preparation, and enhance submission efficiency in response to the RBC-Factory solicitation expected to be published in December 2024. All inquiries should be directed to the provided DARPA contact.
    Lifecycle
    Title
    Type
    RBC-Factory Industry Day
    Currently viewing
    Special Notice
    Similar Opportunities
    Red Blood Cell Factory (RBC-Factory)
    Active
    Dept Of Defense
    The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative proposals for the Red Blood Cell Factory (RBC-Factory) program, aimed at developing a medical device platform to enhance human red blood cells (RBCs) by inserting biologically active components. The primary objective is to create modified red blood cells (mRBCs) that can provide additional protections for warfighters operating in extreme environments, while also assessing the ethical, legal, and social implications (ELSI) of this technology. This initiative is critical for advancing military medical capabilities and ensuring the operational effectiveness of personnel in challenging conditions. DARPA has allocated approximately $18.1 million for this program, with proposals due by the specified deadlines, and interested parties can contact the BAA Coordinator at RBC-Factory@darpa.mil for further information.
    Microsystem Induced CAtalysis (MICA) Proposers Day
    Active
    Dept Of Defense
    The Defense Advanced Research Projects Agency (DARPA) is hosting an in-person Proposers Day for the Microsystem Induced CAtalysis (MICA) program on January 23, 2025, at Booz Allen Hamilton in McLean, VA. This event aims to foster collaboration among industry, academia, and government in the development of advanced microsystem technologies, focusing on how microsystems can control molecular catalysts and integrate molecular technology with microsystems. Participants will have the opportunity to share their capabilities, discuss potential teaming arrangements, and engage in networking, with registration required by January 15, 2024, and attendance limited to 147 individuals from a maximum of three representatives per organization. For further inquiries, interested parties can contact the BAA Coordinator at DARPA-SN-25-24@darpa.mil.
    Army Data Platform (ADP) ARDAP Industry Day
    Active
    Dept Of Defense
    The Department of Defense, through the Army Contracting Command – Rock Island, is hosting a Virtual Industry Day for the Army Data Platform (ADP) on January 16, 2025, from 1300 to 1630 EST. This event aims to discuss the Government's requirements for the ADP and facilitate dialogue between industry participants and ADP leadership, enhancing understanding of the acquisition strategy and contracting approach. The Industry Day is open to all business types and serves as a platform for potential contractors to engage with the government, although participation does not guarantee a contract award. Interested parties must register via Eventbrite and submit any questions or comments regarding the Draft Section L&M by January 9, 2025, to the designated contacts, Babette Murphy and Maria Vital-Smith, at their respective email addresses.
    TurboFCL
    Active
    Dept Of Defense
    The Defense Advanced Research Projects Agency (DARPA) is hosting a virtual Industry Day for the Turbo Facility Clearance (TurboFCL) initiative, aimed at enhancing the facility security clearance (FCL) process for small and nontraditional vendors. This event, scheduled for January 7, 2025, will focus on discussing the challenges faced by small businesses in navigating the complex FCL application process and aims to promote the development of user-friendly software that simplifies this process, similar to tax preparation tools. The TurboFCL initiative is part of a broader effort by the Department of Defense to increase small business participation in defense contracting by reducing barriers to entry. Interested parties must register for the event by January 3, 2025, and should direct inquiries to Dr. Greg Kuperman at DARPA-SN-25-13@darpa.mil.
    ARPA-H Rare disease AI/ML for Precision Integrated Diagnostics (RAPID) Proposers' Day
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is hosting a Proposers’ Day for the Rare disease AI/ML for Precision Integrated Diagnostics (RAPID) Program. This event, scheduled for January 23, 2025, in San Francisco and virtually, aims to inform potential proposers about the program's objectives, timelines, and the upcoming Innovative Solutions Opening (ISO), focusing on the development of AI and machine learning diagnostic tools for rare diseases. The RAPID initiative emphasizes the integration of fragmented health data to improve diagnostic capabilities, particularly for underserved populations, and spans a total duration of 4.5 years across two phases. Interested parties can reach out to the RAPID Email Box at RAPID@ARPA-H.gov for further information.
    ARPA-H PROactive Solutions for Prolonging Resilience (PROSPR) Proposers' Day
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is hosting a Proposers’ Day on January 24, 2025, to discuss the PROactive Solutions for Prolonging Resilience (PROSPR) Program. This initiative aims to develop innovative interventions that extend healthspan by addressing age-related health decline and accelerating the research and development of therapeutics, focusing on three key areas: creating an intrinsic capacity score for health outcomes, repurposing FDA-approved drugs, and advancing preclinical interventions. The event will be held in a hybrid format in Dallas, Texas, and virtually, promoting engagement and collaboration within the research community, with registration required by January 21, 2025. Interested parties can connect with potential collaborators by submitting "teaming profiles" and can reach out to the PROSPR Email Box at PROSPR@arpa-h.gov for further information.
    2025 CB Warfighter Engagements
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Threat Reduction Agency (DTRA), is seeking innovative technologies for the 2025 CB Warfighter Engagements aimed at enhancing capabilities in chemical, biological, and radiological (CBR) defense. This Request for Information (RFI) invites participation from industry and academia to develop technologies that will assist Warfighters in understanding, protecting against, and mitigating CBR threats, with a focus on three key events scheduled for April and June 2025. The initiative emphasizes the importance of rugged prototypes for hands-on evaluation and aims to foster collaboration between technology developers and military users to optimize defense readiness in contested environments. Interested parties should submit their proposals by December 30, 2024, and can direct inquiries to DTRA RD-CBW Submissions at dtra.belvoir.rd.mbx.rd-cbw-submissions@mail.mil.
    Biological Technologies
    Active
    Dept Of Defense
    The Defense Advanced Research Projects Agency (DARPA) is soliciting proposals for innovative research and development in Biological Technologies under the Broad Agency Announcement (BAA) HR001124S0034. This initiative aims to explore revolutionary ideas not currently addressed by existing programs, focusing on areas such as machine learning, human performance, materials technology, and biosecurity, all intended to enhance national security. Proposals will be evaluated based on scientific merit, relevance to DARPA's mission, and cost realism, with submissions accepted on a rolling basis until September 10, 2025. Interested parties can contact the BAA Coordinator at BTOBAA2024@darpa.mil for further information.
    Request for Project Information: “Single Blood Donor Collection and Storage Bags Manufactured in Continental United States (CONUS)”
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Health Agency (DHA) and the U.S. Army Medical Research and Development Command (USAMRDC), is seeking information on the manufacturing capabilities for single blood donor collection and storage bags produced within the contiguous United States. This Request for Project Information (RPI) aims to address critical shortages of blood storage bags necessary for military operations, particularly in trauma situations where timely access to blood products can be life-saving. Interested parties are invited to submit Project Information Papers detailing their compliance with regulatory standards, manufacturing capabilities, and plans to produce a prototype system within two years, with submissions due by January 6, 2025. For further inquiries, contact Dr. Chuck Hutti at chuck.hutti@ati.org or Mr. Evan Kellinger at mtec-sc@ati.org.
    Ocular Laboratory for Analysis of Biomarkers (OCULAB)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is announcing a Proposers' Day for the Ocular Laboratory for Analysis of Biomarkers (OCULAB) program. This initiative aims to develop non-invasive diagnostic technologies for ocular and systemic conditions, particularly focusing on dry eye disease, through two primary technical areas: sensor technology for continuous biomarker monitoring and closed-loop therapeutic dosing systems. The Proposers' Day, scheduled for December 12, 2024, in Tampa Bay, Florida, will facilitate collaboration among participants and provide insights into the program's goals, with registration open from October 18, 2024, to December 5, 2024. Interested parties can contact OCULAB@ARPA-H.gov for further information and are encouraged to register for the event to enhance their proposal submissions.